Daniel Hoit, MD
Neurological Surgery · Memphis, TNNPI 1902000698
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Microvention, Inc. accounts for 60.9% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2019 at $234,092 and has fallen 82.3% since, to $41,492 in 2025. Among neurological surgery clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 726 payments — averaging $835.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microvention, Inc.$369K
- Medtronic$128K
- Stryker$79K
- Siemens Medical Solutions USA, Inc.$13K
- Sequent Medical, Inc.$8K
- Imperative Care, Inc$2K
- plus $7K from 22 others
Across 109 payments — averaging $8039.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$654K
- Imperative Care, Inc$74K
- Medtronic$54K
- Penumbra, Inc.$42K
- Stryker$34K
- Balt USA, LLC$18K
- plus $750 from 2 others
What the payments were for
- Consulting fees$168,77628%
- Speaking & faculty fees$320,38653%
- Travel & lodging$81,43313%
- Food & beverage$15,3633%
- Other$20,6943%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microvention, Inc. | 290 | $369,403 |
| Medtronic(2 entities) | 163 | $127,936 |
| Stryker | 121 | $78,685 |
| Siemens Medical Solutions USA, Inc. | 11 | $13,097 |
| Sequent Medical, Inc. | 2 | $8,400 |
| Imperative Care, Inc | 42 | $2,385 |
| Penumbra, Inc. | 13 | $1,961 |
| Relievant Medsystems, Inc. | 8 | $1,051 |
| Johnson & Johnson | 32 | $840 |
| Abbott | 7 | $760 |
| Rapid Medical Ltd | 5 | $506 |
| Zimmer Biomet | 4 | $290 |
| Balt USA, LLC | 2 | $202 |
| Silk Road Medical, Inc. | 1 | $189 |
| Medical Device Business Services, Inc. | 1 | $142 |
| Boston Scientific | 5 | $134 |
| Qapel Medical Inc | 3 | $128 |
| Centinel Spine, LLC | 1 | $103 |
| Globus Medical | 1 | $102 |
| MIVI Neuroscience, Inc. | 1 | $75 |
| Scientia Vascular | 2 | $58 |
| Route 92 Medical, Inc. | 1 | $53 |
| Orthofix Medical, Inc. | 4 | $43 |
| Amneal Pharmaceuticals LLC | 2 | $30 |
| Mizuho America, Inc. | 1 | $29 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Asahi Intecc USA, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WEB$250,419
- WEB Aneurysm Embolization System$124,787
- SURPASS EVOLVE$56,309
- Pipeline$50,668
- CD HORIZON$20,711
- EVOLVE PROLINE$14,750
- TREVO$12,336
- CATALYFT PL EXPANDABLE INTERBODY SYSTEM$8,700
- UNIVERSAL NEURO 3$3,772
- Intracept$3,667
- EVOLVE$1,639
- ZOOM 88-T LARGE DISTAL PLATFORM$1,213
- 1488, IDEAL EYES$1,170
- Penumbra System$1,049
- CD HORIZON SPINAL SYSTEM$600
- AVS ANCHOR-C$571
- RED 72$560
- STENT$508
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$494
- COMANECI 17$494
How this compares
$606,651 in reported general payments places this provider in the 95th percentile of 156 neurological surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 11 | $4,799 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $196 |
| ClopidogrelClopidogrel Bisulfate | 30 | $158 |
| Gabapentin | 14 | $61 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $14 | $4,79911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 156 neurological surgery providers in Tennessee.
Other neurological surgery in Memphis
- Kevin FoleyMemphis$162.4M
- Maurice SmithMemphis$4.4M
- Adam ArthurMemphis$1.9M
- Paul ParkMemphis$1.2M
- Jason GerrardMemphis$112K
- Earl JonesMemphis$59K
- Demi DawkinsMemphis$56K
- Isaac PomeraniecMemphis$56K
- Kyle SmithMemphis$48K
- Christopher NickeleMemphis$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.